Partnership Will Fund Breakthrough Research to Support the Discovery of Promising New Treatments for TNBC Patients
DALLAS, Jan. 12 /PRNewswire/ -- When her doctor told her she had breast cancer, Sonja Draught thought detecting it early had greatly enhanced her odds of living because that is the case for most forms of cancer. But then she learned she was battling a rare and aggressive form of the disease: triple negative breast cancer.
"When I was first diagnosed with breast cancer, I immediately thought early detection had really saved my life. Then I was told I had the 'bad' cancer," said Draught of Warren, Ohio. "I immediately thought how can all this research, awareness and donations be going to breast cancer and I'm being told my prognosis is bad at stage 1?"
To help women like Draught, Susan G. Komen for the Cure(R) announced it is teaming up with the Triple Negative Breast Cancer Foundation (TNBCF) to fund breakthrough life-saving research about this form of the disease.
At the recent Triple Negative Breast Cancer Symposium in San Antonio, Hala Moddelmog, Komen for the Cure president and CEO, along with Hayley Dinerman, TNBCF director of operations and Allison Axenrod, TNBCF executive director, signed an agreement to help launch The Susan G. Komen for the Cure Promise Grant Co-Funded by the Triple Negative Breast Cancer Foundation.
"This type of research is exactly what we've been looking for," said Dinerman. "By co-funding a Promise Grant with Susan G. Komen for the Cure, we can be certain that the project chosen will be an important, multi-faceted, multi-institutional triple negative-specific research initiative with real world clinical impact."
|SOURCE Susan G. Komen for the Cure|
Copyright©2009 PR Newswire.
All rights reserved